Close
FINDING CURES TOGETHER<sup>SM</sup>

FDA Expands Use of Pembrolizumab to Fourth Cancer Type

This blog post covers the recent FDA approval expanding the use of the immunotherapeutic pembrolizumab (Keytruda) to include the treatment of certain patients with Hodgkin lymphoma.

AACR in the News

Empty Labs: What Medical Research Without Immigrants Looks Like

U.S.News and World Report discusses the "chilling effects of losing the talents of foreign-born scientists in U.S. labs and includes an interview with AACR Past President Carlos Arteaga, MD.